Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation

Journal of Clinical Apheresis

Volumn 19, Issue 3, 2004, Pages 151-153

  Hofling, A Alex ^a   Sands, Mark S ^a   Lublin, Douglas M ^a   Bauer, Gerhard ^a   Devine, Steven ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

glucuronidase; Gene therapy; Lysosomal storage disease; Sly syndrome

Indexed keywords

ALKALINE PHOSPHATASE; CD34 ANTIGEN; EMLA; GRANULOCYTE COLONY STIMULATING FACTOR; LORAZEPAM;

ADULT; ANEMIA; APHERESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; CELL ISOLATION; ENZYME ACTIVITY; FEVER; FLOW CYTOMETRY; GENE THERAPY; HEMATOCRIT; HEMATOPOIETIC STEM CELL; HUMAN; MAGNETIC SEPARATION; MALE; MUCOPOLYSACCHARIDOSIS TYPE 7; SAFETY; STEM CELL MOBILIZATION;

ADULT; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; GENE THERAPY; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS VII;

EID: 6344219880     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20018     Document Type: Article

References (11)

1. Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 1973;82:249-257.
2. Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inh Met Dis 1995;18:398-412.
3. Yamada Y, Kato K, Sukegawa K, et al. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 1998;21:629-634.
4. Peterson L, Parkin J, Nelson A. Mucopolysaccharidosis type VII: a morphologic, cytochemical, and ultrastructural study of the blood and bone marrow. Am J Clin Pathol 1982;78:544-548.
5. deKremer RD, Givorgi I, Argarana CE, Hliba E, Conci R, Boldini CD, Capra AP. Mucopolysaccharidosis type VII (βγρ-glucuronidase deficiency): a chronic varient with an oligosymptomatic severe skeletal dysplasia. Am J Med Genet 1992;44:145-152.
6. Nimgaonkar M, Mierski J, Beeler M, et al. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy. Exp Hematol 1995;23:1633-1641. [Erratum appears in Exp Hematol 1996;24:398.]
7. Nimgaonkar M, Mierski J, Beeler M, et al. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy. Exp Hematol 1995;23:1633-1641. [Erratum appears in Exp Hematol 1996;24:398.]
8. Hubel A, Stroncek D, Pan D, Whitley CB, McCullough J. Mobilization and transduction of peripheral blood progenitor cells in patients with mucopolysaccharidosis I. J Hemat 1998;7:505-514.
9. Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RVB, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, Karlsson S. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: In vivo detection of transduced cells without myeloablation. Hum Gene Ther 1998;9:2629-2640.
10. Lee JE, Falk RE, Ng WG, Donnell GN. Beta-glucuronidase deficiency. A heterogeneous mucopolysaccharidosis. Am J Dis Child 1985;139:57-59.
11. Hofling AA, Devine SM, Vogler C, Sands MS. Human hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease. Mol Ther 2004;9:856-865.